Chemotherapy News and Research

Latest Chemotherapy News and Research

Synthetic cannabis-like drug found to be safe and effective in treating sleep apnea

A synthetic cannabis-like drug in a pill was safe and effective in treating obstructive sleep apnea in the first large multi-site study of a drug for apnea funded by the National Institutes of Health. The study was conducted at Northwestern Medicine and the University of Illinois at Chicago.

28 Nov 2017

New molecule demonstrates ability to block lymphoma growth

The prestigious scientific journal Clinical Cancer Research has published a study conducted by the research group led by Dr. Francesco Bertoni of the Institute of Oncology Research, that have tested a new molecule that demonstrates its ability to inhibit lymphoma growth.

28 Nov 2017

Heated and deep-pocketed battle erupts over 340B drug discount program

A 25-year-old federal drug discount program has grown so big and controversial that it faces a fight for survival as federal officials and lawmakers furiously debate the program's reach.

28 Nov 2017

New findings offer hope for children with aggressive brain tumors

Findings published in Oncotarget offer new hope for children with highly aggressive brain tumors like atypical teratoid/rhabdoid tumor (AT/RT) and medulloblastoma.

28 Nov 2017

New cancer drug begins clinical trial in human patients with rare brain tumor

A drug that spurs cancer cells to self-destruct has been cleared for use in a clinical trial of patients with anaplastic astrocytoma, a rare malignant brain tumor, and glioblastoma multiforme, an aggressive late-stage cancer of the brain.

28 Nov 2017

Study finds unexpected new drug target for acute myeloid leukemia

A study has found an unexpected new drug target for acute myeloid leukemia (AML) that could open new avenues to develop effective treatments against this potentially lethal disease.

27 Nov 2017

Marketplace confusion opens door to questions about skinny plans

Consumers coping with the high cost of health insurance are the target market for new plans claiming to be lower-cost alternatives to the Affordable Care Act that fulfill the law's requirement for health coverage.

27 Nov 2017

High levels of natural immune suppressor in leukemia patients linked to poor survival

Patients diagnosed with the most common form of leukemia who also have high levels of an enzyme known to suppress the immune system are most likely to die early, researchers say.

27 Nov 2017

Adults that survived childhood cancer are at risk of developing hypertension, study reveals

A new study, published in Cancer Epidemiology, Biomarkers & Prevention, indicates that adult survivors of childhood cancer were found to have a twofold increased risk of hypertension (high blood pressure) as adults, when compared with the general population.

24 Nov 2017

Study uncovers key mechanism by which tumors develop resistance to radiation therapy

A Ludwig Cancer Research study has uncovered a key mechanism by which tumors develop resistance to radiation therapy and shown how such resistance might be overcome with drugs that are currently under development.

23 Nov 2017

Childhood cancer survivors more likely to have high blood pressure as adults

People who survived childhood cancer were more than twice as likely as the general population to have high blood pressure (hypertension) as adults.

22 Nov 2017

‘Chemo brain’ may start as tumors form and develop, suggests study

The memory and thinking problems experienced by cancer survivors, known as "chemo brain" or "chemo fog," are not just the result of chemotherapy treatment, they may start as tumors form and develop, suggests a Baycrest-led study.

21 Nov 2017

UVA scientists working to find end-around method to stop triple-negative breast cancer

So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities.

20 Nov 2017

Over-the-counter decongestant found to be effective inhibitor of tumor stroma

CANCER researchers seeking non-toxic alternatives to harmful chemotherapy are reporting a highly significant result for a humble cold remedy.

20 Nov 2017

Study: Alectinib 600 mg more effective than standard therapy in Asian ALK positive NSCLC patients

A subanalysis of the phase III ALEX study has shown that alectinib 600 mg twice daily is more effective than standard of care crizotinib in Asian patients with anaplastic lymphoma kinase (ALK) positive non-small-cell lung cancer (NSCLC), researchers report at the ESMO Asia 2017 Congress.

20 Nov 2017

Study highlights need for more effective approaches to provide cancer survivorship care

Cancer-related effects and the treatment itself can have a significant psychosocial impact on cancer survivors. A recent study (STEP study) that assessed over 1800 cancer survivors across ten countries in Asia Pacific was presented at the ESMO Asia Congress today.

20 Nov 2017

Chemotherapy News and Research

Latest Chemotherapy News and Research

Synthetic cannabis-like drug found to be safe and effective in treating sleep apnea

New molecule demonstrates ability to block lymphoma growth

Heated and deep-pocketed battle erupts over 340B drug discount program

New findings offer hope for children with aggressive brain tumors

New cancer drug begins clinical trial in human patients with rare brain tumor

Study finds unexpected new drug target for acute myeloid leukemia

Marketplace confusion opens door to questions about skinny plans

High levels of natural immune suppressor in leukemia patients linked to poor survival

Adults that survived childhood cancer are at risk of developing hypertension, study reveals

Study uncovers key mechanism by which tumors develop resistance to radiation therapy

Childhood cancer survivors more likely to have high blood pressure as adults

‘Chemo brain’ may start as tumors form and develop, suggests study

UVA scientists working to find end-around method to stop triple-negative breast cancer

Over-the-counter decongestant found to be effective inhibitor of tumor stroma

Study: Alectinib 600 mg more effective than standard therapy in Asian ALK positive NSCLC patients

Study highlights need for more effective approaches to provide cancer survivorship care

Study confirms safety and efficacy of new second line treatment for metastatic colorectal cancer

Hibernating ground squirrels offer clues to fight against stroke-induced brain damage

Breakthrough research brings new procedure closer to helping patients with blood cancer

Researchers develop computer program to find new indications for old drugs

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in